Advanced search
Publication Cover
Modern Rheumatology Volume 25, 2015 - Issue 5
Journal homepage
311
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Early achievement of complete renal response predicts good long-term renal outcome and low systemic damage in newly diagnosed lupus nephritis class III or IV

Hironari HanaokaDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, JapanCorrespondence[email protected]
,
Yuko KanekoDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
,
Masataka KuwanaDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan;Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan
&
Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
Pages 714-718 | Received 27 Oct 2014, Accepted 26 Dec 2014, Published online: 11 Feb 2015

References

  • Baldwin DS, Gluck ML, Lowenstein J, Gallo GR. Lupus nephritis: clinical course of related to morphologic forms and their transitions. Am J Med. 1977;62(1):12–30.
  • Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel BD, et al. The classification of glomerulonephritis in systemic lupus erythematosus revised. J Am Soc Nephrol. 2004;15(2):241–50.
  • Borchers AT, Leibushor N, Naguwa SM, Cheema GS, Shoenfeld Y, Gershwin ME. Lupus nephritis: a critical review. Autoimmun Rev. 2012;12(2):174–94.
  • Austin HA, Boumpas DT, Vaughman EM, Balow JE. Predicting renal outcome in severe lupus nephritis: Contributions of clinical and histologic data. Kidney Int. 1994;45(2):544–50.
  • Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984;25(4):689–95.
  • Magil AB, Puterman ML, Ballon HS, Chan V, Lirenman DS, Rae A, Sutton RA. Prognostic factors in diffuse proliferative lupus glomerulonephritis. Kidney Int. 1988;34(4):511–7.
  • Houssiau FA, Vasconcelos C, D’Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term follow up of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum. 2004;50(12):3934–40.
  • Alsuwaida A, Husain S, Alghonaim M, AlOudah N, Alwakeel J, Ullah A, Kfoury H. Strategy for kidney biopsy in patients with lupus nephritis. Nephrol Dial Transplant. 2012;27(4):1472–8.
  • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
  • Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630–40.
  • Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, et al. The Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–82.
  • Petri M, Buyon J, Kim M. Classification and definition of major flares in SLE clinical trials. Lupus. 1999;8(8):685–91.
  • Gladman D, Ginzler E, Goldsmith CH, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus Erythematosus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39(3):363–9.
  • Rahman P, Gladman DD, Urowitz MB, Hallet D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus. 2001; 10(2):93–6.
  • Stahl-Hallengren C, Jönsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000;27(3):685–91.
  • Urowitz MB, Bookman AAM, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976;60(2):221–5.
  • van Vollenhoven, Mosca M, Bertsias G, Isenberg D, Kuhn A, Lerstrom K, et al. Treat-to-target in systemic lupus erythematosus: recommendation from an international task force. Ann Rheum Dis. 2014;73(6):958–67.
  • Ramanujam M, Bethunaickan R, Huang W, Tao H, Madaio MP, Davidson A. Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice. Arthritis Rheum. 2010;62(5):1457–68.
  • van Nies JA, Krabben A, Schoones JW, Huizinga TW, Kloppenburg M, van der Helm-van Mil AH. What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis. 2014;73(5):861–70.
  • Touma Z, Urowitz MB, Ibanez D, Gladman DD. Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment. J Rheumatol. 2014;41(4):688–97.
  • Lopez R, Davidson JE, Beeby MD, Egger PJ, Isenberg DA. Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort. Rheumatology. 2012;51(3):491–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.